Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 187

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

SERCA2a Gene Transfer Decreases Sarcoplasmic Reticulum Calcium Leak and Reduces Ventricular Arrhythmias in a Model of Chronic Heart Failure

Open access
Lyon, Alexander R., Bannister, Mark L., Collins, Tom, Pearce, Emma, Sepehripour, Amir H., Dubb, Sukhpreet S., Garcia, Edwin, O'Gara, Peter, Liang, Lifan, Kohlbrenner, Erik, Hajjar, Roger J., Peters, Nicholas S., Poole-Wilson, Philip A., Macleod, Ken T., Harding, Sian E.·2011·Circulation: Arrhythmia and Electrophysiology

Abstract

Background—: Sarcoplasmic reticulum calcium ATPase 2a (SERCA2a) gene therapy improves mechanical function in heart failure and is under evaluation in a clinical trial. A critical question is whether SERCA2a gene therapy predisposes to increased sarcoplasmic reticulum calcium (SR Ca 2+ ) leak, cellular triggered activity, and ventricular arrhythmias in the failing heart. Methods and Results—: We studied the influence of SERCA2a gene therapy on ventricular arrhythmogenesis in a rat chronic heart failure model. ECG telemetry studies revealed a significant antiarrhythmic effect of SERCA2a gene therapy with reduction of both spontaneous and catecholamine-induced arrhythmias in vivo. SERCA2a gene therapy also reduced susceptibility to reentry arrhythmias in ex vivo programmed electrical stimulation studies. Subcellular Ca 2+ homeostasis and spontaneous SR Ca 2+ leak characteristics were measured in failing cardiomyocytes transfected in vivo with a novel AAV9.SERCA2a vector. SR Ca 2+ leak was reduced after SERCA2a gene therapy, with reversal of the greater spark mass observed in the failing myocytes, despite normalization of SR Ca 2+ load. SERCA2a reduced ryanodine receptor phosphorylation, thereby resetting SR Ca 2+ leak threshold, leading to reduced triggered activity in vitro. Both indirect effects of reverse remodeling and direct SERCA2a effects appear to underlie the antiarrhythmic action. Conclusions—: SERCA2a gene therapy stabilizes SR Ca 2+ load, reduces ryanodine receptor phosphorylation and decreases SR Ca 2+ leak, and reduces cellular triggered activity in vitro and spontaneous and catecholamine-induced ventricular arrhythmias in vivo in failing hearts. SERCA2a gene therapy did not therefore predispose to arrhythmias and may represent a novel antiarrhythmic strategy in heart failure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circep.110.961615

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 187

Metadata

Authors
Lyon, A. R., Bannister, M. L., Collins, T., Pearce, E., Sepehripour, A. H., Dubb, S. S., Garcia, E., O'Gara, P., Liang, L., Kohlbrenner, E., Hajjar, R. J., Peters, N. S., Poole-Wilson, P. A., Macleod, K. T., & Harding, S. E.
Venue
Circulation: Arrhythmia and Electrophysiology
Published
2011-06
Volume
4
Issue
3
Pages
362-372
ISSN
  • 1941-3084 (ISSN-L)
  • 1941-3149
OpenAlex
W1764072566
Cited by
187
References
1
FWCI
13.33
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SERCA2a Gene Transfer Decreases Sarcoplasmic Reticulum Calcium Leak and Reduces Ventricular Arrhythmias in a Model of Chronic Heart Failure. https://app.cochat.ai/papers/10.1161/circep.110.961615
The paper
Lyon, A. R., Bannister, M. L., Collins, T., Pearce, E., Sepehripour, A. H., Dubb, S. S., Garcia, E., O'Gara, P., Liang, L., Kohlbrenner, E., Hajjar, R. J., Peters, N. S., Poole-Wilson, P. A., Macleod, K. T., & Harding, S. E. (2011). SERCA2a Gene Transfer Decreases Sarcoplasmic Reticulum Calcium Leak and Reduces Ventricular Arrhythmias in a Model of Chronic Heart Failure. Circulation: Arrhythmia and Electrophysiology. https://doi.org/10.1161/circep.110.961615

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.